Other Names: Mogibacterium Mogibacterium Nakazawa et al. 2000
Change Display Name to
Desired Levels from Some Experts
Ranges can vary from lab to lab because of different equipment and software being used.
Possible Health Impacts
I would like to know about this bacteria's
Citizen Science 2.0 Explorer. List is restricted to associations with a high count and a change of random occurance greater than 1 in 100.
|General: Fatigue||Between 50%ile to 100%ile||1 to 44388|
|Neuroendocrine Manifestations: worsening of symptoms with stress.||Between 50%ile to 100%ile||1 to 24853.2|
|Neurological: Impairment of concentration||Between 50%ile to 100%ile||1 to 19777.5|
|Post-exertional malaise: Mentally tired after the slightest effort||Between 50%ile to 100%ile||1 to 14074.1|
|Sleep: Need to nap daily||Between 50%ile to 100%ile||1 to 7205.2|
|Neurocognitive: Absent-mindedness or forgetfulness||Between 50%ile to 100%ile||1 to 5211.9|
|Neurological: Impairment of concentration||Between 66%ile to 100%ile||1 to 4831.6|
|Neurocognitive: Slowness of thought||Between 50%ile to 100%ile||1 to 3625|
|Sleep: Unrefreshed sleep||Between 50%ile to 100%ile||1 to 2816.6|
|Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic||Low||1|
A P-value below 0.0001 is the recommended threshold. A larger R-Square value means a stronger relationship. This is unpublished data using Properitary Artificial Intelligence.